Trial intelligence / Profile preview

NST Nutritional Management in Esophageal Cancer

NCT05800054Recruiting

Sponsor
Jiangsu Provincial People's Hospital
Start
Jan 2021
Primary completion
Dec 2024
Countries
1
01

Overview

Randomised, open-label trial in Esophageal Squamous Cell Carcinoma (ESCC) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Body weight at 3 years and Body Mass Index at 3 years. Started Jan 2021; status: recruiting.

02

Conditions

Esophageal Squamous Cell Carcinoma (ESCC)

Beyond the preview

Go deeper on NCT05800054.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05800054.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call